Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:3590 |
Name | gestational trophoblastic neoplasm |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | DOID:3598 DOID:14071 |
Path | disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer female reproductive organ cancer uterine cancer endometrial cancer gestational trophoblastic neoplasm |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01535053 | Phase III | Leucovorin Dactinomycin Methotrexate | Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | Completed | USA | GBR | CAN | 2 |
NCT03135769 | Phase II | Avelumab | Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias (TROPHIMMUN) | Completed | FRA | 0 |
NCT04396223 | Phase Ib/II | Avelumab + Methotrexate | Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment (TROPHAMET) | Recruiting | FRA | 0 |
NCT05405192 | Phase II | Dostarlimab-gxly | Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia | Withdrawn | USA | 0 |
NCT06790706 | Phase II | AB154 + Zimberelimab AB154 + Fluorouracil + Leucovorin + Oxaliplatin + Zimberelimab | IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers (IMMUNORARE5) | Not yet recruiting | FRA | 0 |